Apeiron Biologics (dinutuximab beta) is Buildings and Property in Austria that focus on global commercialization rights business. They cover business area such as Isqette, dinutuximab beta, Dinutuximab beta, high risk neuroblastoma, Europe.
-
Global Commercialization Rights
-
Vienna
Austria
Private
Isqettedinutuximab betaDinutuximab betahigh risk neuroblastomaEurope
* We use standard office opening hours in near Apeiron Biologics (dinutuximab beta)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Apeiron Biologics (dinutuximab Beta) is Buildings and Property business from Austria that founded in - ( years old in ), Apeiron Biologics (dinutuximab beta) business is focusing on Global Commercialization Rights.
Apeiron Biologics (dinutuximab beta) headquarter office and corporate office address is located in Vienna Austria.
Apeiron Biologics (dinutuximab beta) was founded in Austria.
In , Apeiron Biologics (dinutuximab beta) is currently focus on global commercialization rights sector.
Above is snippet of Google Trends for "global commercialization rights" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Apeiron Biologics (dinutuximab beta), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
